A Study to Compare Disease Progression and Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics in Participant's With Recent-onset Schizophrenia or Schizophreniform

Clinical trial NCT02431702 · COMPLETED

Trial details

NCT number: NCT02431702
Sponsor: Janssen Scientific Affairs, LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Schizophrenia Psychotic Disorders

Start date: 2015-07-08
Primary completion: 2019-11-12
Enrollment: 337

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.